CO2021009379A2 - Formulaciones y métodos de la vacuna contra el norovirus - Google Patents
Formulaciones y métodos de la vacuna contra el norovirusInfo
- Publication number
- CO2021009379A2 CO2021009379A2 CONC2021/0009379A CO2021009379A CO2021009379A2 CO 2021009379 A2 CO2021009379 A2 CO 2021009379A2 CO 2021009379 A CO2021009379 A CO 2021009379A CO 2021009379 A2 CO2021009379 A2 CO 2021009379A2
- Authority
- CO
- Colombia
- Prior art keywords
- methods
- vaccine formulations
- norovirus vaccine
- norovirus
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241001263478 Norovirus Species 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782733P | 2018-12-20 | 2018-12-20 | |
| PCT/US2019/067961 WO2020132510A1 (en) | 2018-12-20 | 2019-12-20 | Norovirus vaccine formulations and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2021009379A2 true CO2021009379A2 (es) | 2021-08-30 |
Family
ID=71101884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2021/0009379A CO2021009379A2 (es) | 2018-12-20 | 2021-07-19 | Formulaciones y métodos de la vacuna contra el norovirus |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220054621A1 (https=) |
| EP (1) | EP3897712A4 (https=) |
| JP (1) | JP2022514759A (https=) |
| KR (1) | KR20210114941A (https=) |
| CN (1) | CN113453711A (https=) |
| AR (1) | AR117462A1 (https=) |
| AU (1) | AU2019404430A1 (https=) |
| BR (1) | BR112021012181A2 (https=) |
| CA (1) | CA3123860A1 (https=) |
| CO (1) | CO2021009379A2 (https=) |
| IL (1) | IL284233A (https=) |
| MX (1) | MX2021007502A (https=) |
| SG (1) | SG11202106628YA (https=) |
| WO (1) | WO2020132510A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740624B (zh) | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| EP4112074A1 (en) | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| WO2022143282A1 (zh) * | 2020-12-30 | 2022-07-07 | 远大赛威信生命科学(南京)有限公司 | 诺如病毒病毒样颗粒、免疫组合物或试剂盒及其用途 |
| US20240238401A1 (en) | 2021-05-21 | 2024-07-18 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| WO2024202045A1 (ja) * | 2023-03-31 | 2024-10-03 | デンカ株式会社 | 腸管へのウイルス特異的な抗体誘導が可能なノロウイルスワクチン |
| WO2025076792A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Product Co., Ltd. | Methods of preparing norovirus vaccine with low amounts of adjuvant |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2514316T3 (es) * | 2005-11-22 | 2014-10-28 | Novartis Vaccines And Diagnostics, Inc. | Partículas similares a virus (VLPs) de Norovirus y Sapovirus |
| CN104740624B (zh) * | 2007-09-18 | 2018-04-24 | 武田疫苗股份有限公司 | 赋予针对诺如病毒的保护性免疫应答的疫苗 |
| NO2324113T3 (https=) * | 2008-08-08 | 2018-07-28 | ||
| US20110070260A1 (en) * | 2009-09-09 | 2011-03-24 | Baric Ralph S | Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| CA2787666A1 (en) * | 2010-01-21 | 2011-07-28 | Ligocyte Pharmaceuticals, Inc. | Targeted heterologous antigen presentation on calicivirus virus-like particles |
| EP4112074A1 (en) * | 2011-07-11 | 2023-01-04 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
-
2019
- 2019-12-19 AR ARP190103785A patent/AR117462A1/es not_active Application Discontinuation
- 2019-12-20 CA CA3123860A patent/CA3123860A1/en active Pending
- 2019-12-20 WO PCT/US2019/067961 patent/WO2020132510A1/en not_active Ceased
- 2019-12-20 BR BR112021012181-1A patent/BR112021012181A2/pt unknown
- 2019-12-20 SG SG11202106628YA patent/SG11202106628YA/en unknown
- 2019-12-20 KR KR1020217020497A patent/KR20210114941A/ko not_active Withdrawn
- 2019-12-20 AU AU2019404430A patent/AU2019404430A1/en active Pending
- 2019-12-20 MX MX2021007502A patent/MX2021007502A/es unknown
- 2019-12-20 CN CN201980092246.7A patent/CN113453711A/zh active Pending
- 2019-12-20 EP EP19901048.9A patent/EP3897712A4/en active Pending
- 2019-12-20 US US17/416,810 patent/US20220054621A1/en active Pending
- 2019-12-20 JP JP2021535827A patent/JP2022514759A/ja active Pending
-
2021
- 2021-06-20 IL IL284233A patent/IL284233A/en unknown
- 2021-07-19 CO CONC2021/0009379A patent/CO2021009379A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022514759A (ja) | 2022-02-15 |
| US20220054621A1 (en) | 2022-02-24 |
| SG11202106628YA (en) | 2021-07-29 |
| AU2019404430A1 (en) | 2021-07-08 |
| CN113453711A (zh) | 2021-09-28 |
| WO2020132510A1 (en) | 2020-06-25 |
| KR20210114941A (ko) | 2021-09-24 |
| BR112021012181A2 (pt) | 2021-08-31 |
| CA3123860A1 (en) | 2020-06-25 |
| AR117462A1 (es) | 2021-08-04 |
| IL284233A (en) | 2021-08-31 |
| EP3897712A4 (en) | 2022-08-31 |
| MX2021007502A (es) | 2021-10-13 |
| EP3897712A1 (en) | 2021-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021009379A2 (es) | Formulaciones y métodos de la vacuna contra el norovirus | |
| EP4366768A4 (en) | Pan-human coronavirus vaccines | |
| BR112017001796A2 (pt) | composições de flagelina e seus usos | |
| ECSP18001613A (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| PL3585803T3 (pl) | Formulacje skoniugowanych szczepionek przeciwko pneumokokom | |
| EP3668541A4 (en) | FORMULATIONS FOR PNEUMOCOCCAL CONJUGATE VACCINE | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| UY37563A (es) | Aislados de bacillus y usos de los mismos | |
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| MX2018001755A (es) | Vacuna contra viruela para tratamiento del cancer. | |
| MX2018007198A (es) | Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos. | |
| DK3197489T3 (da) | Fremgangsmåder og sammensætninger til at fremkalde beskyttende immunitet over for human immundefekt virusinfektion | |
| MX2023012390A (es) | Vacunacion con particulas de replicon y adyuvante oleoso. | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| EA201790507A1 (ru) | Способы и композиции для усиления иммунных ответов | |
| CU20180025A7 (es) | Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue | |
| MX2020011712A (es) | Vacunas de nanoparticulas multivalentes contra la influenza. | |
| CL2015002273A1 (es) | Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o una infección limitante por eimeria | |
| MX2018016306A (es) | Virus de enteritis de pato y usos del mismo. | |
| MX2016016746A (es) | Composiciones de vacuna con adyuvante dual, preparacion y usos. | |
| CO2018010359A2 (es) | Constructos de alfavirus vivo atenuado y métodos y usos de los mismos | |
| MX381252B (es) | Virus de la enteritis del pato y usos del mismo. | |
| IL313254A (en) | Coronavirus vaccine formulations | |
| CL2018000253A1 (es) | Respuesta inmunitaria potenciada de las especies porcinas |